Medtech

WeMed has been testing a robotic-assisted system that executes—like a doctor’s hands— minimal invasive vascular therapy procedures, CEO and founder Yang He says.

Jianjia has developed Arthrobot, a robot which can position, grind, and install prostheses, to aid doctors during joint replacement surgeries.

McCooey, Nasdaq’s head of global capital markets and Asia Pacific, discussed the current IPO trends in China as well as the potential of Southeast Asian unicorns.

CorNeat offers a few innovative solutions, including the CorNeat KPro, an artificial cornea, as well as the CorNeat EverPatch, an artificial connective tissue substitute.

Biofourmis uses AI and machine learning to deliver software-based, data-driven therapies that enable personalized predictive care.

The company offers tools that may make the difference between swift recovery and permanent physical damage in people who suffer strokes.

In 95% of ultrasound videos captured by PulseNmore’s device, the fetus’ heartbeat, movement, and amniotic fluid were detected in three minutes.

See-Mode claims to be first in developing software for automated analysis and reporting of vascular ultrasound scans, approved by the Singapore health authorities.